FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer

Mol Oncol. 2017 Sep;11(9):1302-1303. doi: 10.1002/1878-0261.12118.
No abstract available

Publication types

  • Published Erratum